B. Kim Lee Sim
11Patents
6h-index
8Co-inventors
59Inventor score
Filing activity: Nov 12, 2002 → Apr 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8043625B2 | Purified plasmodium and vaccine compositions | Emerging Cross-Sectional Technologies | 19 | Active |
| US8367810B2 | Purified plasmodium and vaccine compositions | Emerging Cross-Sectional Technologies | 17 | Active |
| US8992944B2 | Purified Plasmodium and vaccine composition | Emerging Cross-Sectional Technologies | 13 | Active |
| US9241982B2 | Purified plasmodium and vaccine compositions | Emerging Cross-Sectional Technologies | 11 | Active |
| US8821896B2 | Purified Plasmodium and vaccine composition | Emerging Cross-Sectional Technologies | 11 | Active |
| US9616115B2 | Purified plasmodium and vaccine compositions | Emerging Cross-Sectional Technologies | 6 | Active |
| US7078507B2 | Synthetic genes for malarial proteins and methods of use | Emerging Cross-Sectional Technologies | 3 | Expired |
| US10272146B2 | Purified plasmodium and vaccine compositions | Emerging Cross-Sectional Technologies | 3 | Active |
| US11324814B2 | Live attenuated oral vaccine against ETEC and typhoid fever | Emerging Cross-Sectional Technologies | 1 | Active |
| US10695415B2 | Live attenuated oral vaccine against shigellosis and typhoid fever | Emerging Cross-Sectional Technologies | 1 | Active |
| US12409213B2 | Live attenuated oral vaccine against shigellosis and typhoid fever | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.